Novartis AG SEC filings NVSEF
Novartis AG has 1,000 filings in SEC EDGAR's recent list, going back to Apr 27, 2009. Its latest annual report, Form 20-F, was filed on Feb 4, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 27, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| IRANNOTICE | Filing | Feb 4, 2026 | — |
| DFAN14A | Filing | Jan 14, 2026 | — |
| DFAN14A | Filing | Jan 12, 2026 | — |
| DFAN14A | Filing | Oct 28, 2025 | — |
| SC TO-T/A | Filing | Oct 28, 2025 | — |
| DFAN14A | Filing | Oct 28, 2025 | — |
| DFAN14A | Filing | Oct 27, 2025 | — |
| DFAN14A | Filing | Oct 27, 2025 | — |
| DFAN14A | Filing | Oct 27, 2025 | — |
| SC TO-T/A | Filing | Oct 22, 2025 | — |
| SC TO-T/A | Filing | Oct 20, 2025 | — |
| SC TO-T | Filing | Sep 29, 2025 | — |
| SC TO-C | Filing | Sep 9, 2025 | — |
| SC TO-T/A | Filing | Jun 25, 2025 | — |
| SC TO-T/A | Filing | Jun 23, 2025 | — |
| SC TO-T/A | Filing | Jun 17, 2025 | — |
| SC TO-T | Filing | May 27, 2025 | — |
| SC TO-C | Filing | May 1, 2025 | — |
| SC TO-C | Filing | Apr 30, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 8, 2025 | — |
| CORRESP | Letter to the SEC | Mar 31, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 18, 2025 | — |
| IRANNOTICE | Filing | Jan 31, 2025 | — |
| SC TO-T/A | Filing | Aug 13, 2024 | — |
| SC TO-T/A | Filing | Aug 7, 2024 | — |
| SC TO-T/A | Filing | Aug 2, 2024 | — |
| SC TO-T/A | Filing | Aug 1, 2024 | — |
| SC TO-T/A | Filing | Jul 31, 2024 | — |
| SC TO-T/A | Filing | Jul 30, 2024 | — |
| SC TO-T/A | Filing | Jul 29, 2024 | — |
| SC TO-T/A | Filing | Jul 25, 2024 | — |
| SC TO-T/A | Filing | Jul 18, 2024 | — |
| SC TO-T/A | Filing | Jul 11, 2024 | — |
| SC TO-T | Filing | Jul 5, 2024 | — |
| SC TO-C | Filing | Jun 20, 2024 | — |
| SC TO-T/A | Filing | Jun 4, 2024 | — |
| SD | Specialized disclosure (conflict minerals) | May 31, 2024 | — |
| SC TO-T/A | Filing | May 24, 2024 | — |
| SC TO-T/A | Filing | May 16, 2024 | — |
| SC TO-T/A | Filing | May 13, 2024 | — |
| SC TO-T/A | Filing | May 10, 2024 | — |
| SC TO-T/A | Filing | May 8, 2024 | — |
| SC TO-T/A | Filing | May 7, 2024 | — |
| SC TO-T/A | Filing | May 6, 2024 | — |
| SC TO-T/A | Filing | May 2, 2024 | — |
| SC TO-T/A | Filing | Apr 25, 2024 | — |
| SC TO-T/A | Filing | Apr 18, 2024 | — |
| SC TO-T/A | Filing | Apr 17, 2024 | — |
| SC TO-T/A | Filing | Apr 16, 2024 | — |
| SC TO-T/A | Filing | Apr 15, 2024 | — |
| SC TO-T | Filing | Apr 11, 2024 | — |
| SC TO-C | Filing | Feb 6, 2024 | — |
| SC TO-C | Filing | Feb 5, 2024 | — |
| IRANNOTICE | Filing | Jan 31, 2024 | — |
| DFAN14A | Filing | Jul 10, 2023 | — |
| DFAN14A | Filing | Jun 12, 2023 | — |
| SD | Specialized disclosure (conflict minerals) | May 31, 2023 | — |
| UPLOAD | Letter from the SEC | May 22, 2023 | — |
| CORRESP | Letter to the SEC | May 9, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 25, 2023 | — |
| IRANNOTICE | Filing | Feb 1, 2023 | — |
| SD | Specialized disclosure (conflict minerals) | May 31, 2022 | — |
| IRANNOTICE | Filing | Feb 2, 2022 | — |
| SD | Specialized disclosure (conflict minerals) | Jun 1, 2021 | — |
| IRANNOTICE | Filing | Jan 26, 2021 | — |
| UPLOAD | Letter from the SEC | Jan 22, 2021 | — |
| CORRESP | Letter to the SEC | Jan 19, 2021 | — |
| UPLOAD | Letter from the SEC | Dec 22, 2020 | — |
| SD | Specialized disclosure (conflict minerals) | Jun 1, 2020 | — |
| POSASR | Post-effective amendment no.1 | Feb 14, 2020 | — |
| IRANNOTICE | Filing | Jan 29, 2020 | — |
| SC TO-T/A | Filing | Jan 6, 2020 | — |
| SC TO-T/A | Filing | Dec 23, 2019 | — |
| SC TO-T/A | Filing | Dec 19, 2019 | — |
| SC TO-T | Filing | Dec 5, 2019 | — |
| SC TO-C | Filing | Nov 25, 2019 | — |
| SC TO-C | Filing | Nov 25, 2019 | — |
| SD | Specialized disclosure (conflict minerals) | May 31, 2019 | — |
| IRANNOTICE | Filing | Jan 30, 2019 | — |
| DFAN14A | Filing | Nov 6, 2018 | — |
| DFAN14A | Filing | Nov 5, 2018 | — |
| DFAN14A | Filing | Oct 18, 2018 | — |
| DFAN14A | Filing | Oct 18, 2018 | — |
| DFAN14A | Filing | Oct 18, 2018 | — |
| DFAN14A | Filing | Oct 18, 2018 | — |
| SD | Specialized disclosure (conflict minerals) | May 31, 2018 | — |
| SC TO-T/A | Filing | May 15, 2018 | — |
| SC TO-T/A | Filing | May 1, 2018 | — |
| SC TO-T | Filing | Apr 17, 2018 | — |
| SC TO-C | Filing | Apr 10, 2018 | — |
| SC TO-C | Filing | Apr 9, 2018 | — |
| SC TO-T/A | Sc to-t | Feb 1, 2018 | — |
| IRANNOTICE | Filing | Jan 24, 2018 | — |
| SC TO-T/A | Sc to-t | Jan 22, 2018 | — |
| SC TO-T/A | Filing | Jan 12, 2018 | — |
| SC TO-T/A | Sc to-t | Dec 21, 2017 | — |
| CORRESP | Letter to the SEC | Dec 21, 2017 | — |
| SC TO-T | Filing | Dec 7, 2017 | — |
| SC TO-C | Filing | Nov 24, 2017 | — |
| SC TO-C | Filing | Oct 30, 2017 | — |
| SD | Specialized disclosure (conflict minerals) | May 31, 2017 | — |
| UPLOAD | Letter from the SEC | May 3, 2017 | — |
| CORRESP | Letter to the SEC | Apr 20, 2017 | — |
| CORRESP | Letter to the SEC | Mar 27, 2017 | — |
| UPLOAD | Letter from the SEC | Mar 23, 2017 | — |
| POSASR | Post-effective amendment no.2 | Feb 17, 2017 | — |
| IRANNOTICE | Filing | Jan 25, 2017 | — |
| SD | Specialized disclosure (conflict minerals) | May 31, 2016 | — |
| CT ORDER | Filing | Feb 17, 2016 | — |
| IRANNOTICE | Filing | Jan 27, 2016 | — |
| POSASR | Post-effective amendment no.1 | Nov 20, 2015 | — |
| UPLOAD | Letter from the SEC | Jul 22, 2015 | — |
| CORRESP | Letter to the SEC | Jul 20, 2015 | — |
| CORRESP | Letter to the SEC | Jun 29, 2015 | — |
| SD | Specialized disclosure (conflict minerals) | Jun 1, 2015 | — |
| UPLOAD | Letter from the SEC | May 26, 2015 | — |
| CT ORDER | Filing | May 14, 2015 | — |
| CORRESP | Letter to the SEC | Apr 24, 2015 | — |
| CORRESP | Letter to the SEC | Apr 7, 2015 | — |
| UPLOAD | Letter from the SEC | Mar 30, 2015 | — |
| IRANNOTICE | Filing | Jan 27, 2015 | — |
| SD | Specialized disclosure (conflict minerals) | Jun 2, 2014 | — |
| POSASR | Post-effective amendment no. 2 | Feb 21, 2014 | — |
| IRANNOTICE | Filing | Jan 29, 2014 | — |
| UPLOAD | Letter from the SEC | Aug 29, 2013 | — |
| CORRESP | Letter to the SEC | Aug 23, 2013 | — |
| CORRESP | Letter to the SEC | Jul 17, 2013 | — |
| CORRESP | Letter to the SEC | Jul 2, 2013 | — |
| UPLOAD | Letter from the SEC | Jun 19, 2013 | — |
| CORRESP | Letter to the SEC | May 23, 2013 | — |
| CORRESP | Letter to the SEC | May 17, 2013 | — |
| UPLOAD | Letter from the SEC | May 3, 2013 | — |
| CORRESP | Letter to the SEC | Apr 3, 2013 | — |
| UPLOAD | Letter from the SEC | Mar 20, 2013 | — |
| IRANNOTICE | Filing | Jan 23, 2013 | — |
| POSASR | Filing | Sep 21, 2012 | — |
| UPLOAD | Letter from the SEC | Aug 14, 2012 | — |
| CORRESP | Letter to the SEC | Jul 26, 2012 | — |
| UPLOAD | Letter from the SEC | Jul 20, 2012 | — |
| CORRESP | Letter to the SEC | Jun 22, 2012 | — |
| UPLOAD | Letter from the SEC | Jun 8, 2012 | — |
| CORRESP | Letter to the SEC | May 10, 2012 | — |
| CORRESP | Letter to the SEC | Apr 25, 2012 | — |
| UPLOAD | Letter from the SEC | Apr 12, 2012 | — |
| UPLOAD | Letter from the SEC | Dec 22, 2011 | — |
| CORRESP | Letter to the SEC | Nov 14, 2011 | — |
| CORRESP | Letter to the SEC | Oct 7, 2011 | — |
| CORRESP | Letter to the SEC | Sep 19, 2011 | — |
| UPLOAD | Letter from the SEC | Sep 9, 2011 | — |
| CORRESP | Letter to the SEC | Sep 6, 2011 | — |
| CORRESP | Letter to the SEC | Aug 26, 2011 | — |
| CORRESP | Letter to the SEC | Aug 15, 2011 | — |
| UPLOAD | Letter from the SEC | Jul 29, 2011 | — |
| CORRESP | Letter to the SEC | Jun 30, 2011 | — |
| CORRESP | Letter to the SEC | Jun 16, 2011 | — |
| UPLOAD | Letter from the SEC | Jun 2, 2011 | — |
| CORRESP | Letter to the SEC | Apr 26, 2011 | — |
| UPLOAD | Letter from the SEC | Apr 11, 2011 | — |
| SC TO-T/A | Filing | Mar 7, 2011 | — |
| SC TO-T/A | Filing | Feb 28, 2011 | — |
| EFFECT | Filing | Feb 25, 2011 | — |
| CORRESP | Letter to the SEC | Feb 23, 2011 | — |
| SC TO-T/A | Filing | Feb 22, 2011 | — |
| UPLOAD | Letter from the SEC | Feb 15, 2011 | — |
| SC TO-T/A | Filing | Feb 7, 2011 | — |
| SC TO-T | Filing | Jan 28, 2011 | — |
| SC TO-C | Filing | Jan 26, 2011 | — |
| SC TO-C | Filing | Jan 24, 2011 | — |
| SC TO-C | Filing | Jan 24, 2011 | — |
| UPLOAD | Letter from the SEC | Jan 21, 2011 | — |
| UPLOAD | Letter from the SEC | Jan 5, 2011 | — |
| 425 | Investor presentation | Dec 15, 2010 | — |
| 425 | Press release | Dec 15, 2010 | — |
| UPLOAD | Letter from the SEC | Jul 20, 2010 | — |
| CORRESP | Letter to the SEC | Jul 1, 2010 | — |
| CORRESP | Letter to the SEC | Jun 25, 2010 | — |
| UPLOAD | Letter from the SEC | Jun 11, 2010 | — |
| CORRESP | Letter to the SEC | May 11, 2010 | — |
| UPLOAD | Letter from the SEC | Apr 30, 2010 | — |
| POSASR | F-3asr | Apr 14, 2010 | — |
| 425 | Filing | Jan 4, 2010 | — |
| 425 | Filing | Jan 4, 2010 | — |
| 425 | Filing | Jan 4, 2010 | — |
| 425 | Filing | Jan 4, 2010 | — |
| 425 | Filing | Jan 4, 2010 | — |
| UPLOAD | Letter from the SEC | Sep 16, 2009 | — |
| CORRESP | Letter to the SEC | Jun 29, 2009 | — |
| UPLOAD | Letter from the SEC | Jun 22, 2009 | — |
Showing 188 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NVS (NYSE), NVSEF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- Switzerland
- Headquarters
- Basel, Switzerland
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1114448
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
- Pfizer Inc PFE
Source: SEC EDGAR filings. This is company-reported data, not investment advice.